Funding announced for Cambridge Cancer Research Hospital
The government has committed to provide funding for the new Cambridge Cancer Research Hospital at Addenbrookeâs.
Prime Minister Boris Johnson announced the funding on Friday 2nd October as part of the Health Infrastructure Plan, committing £3.7 billion for 40 hospitals across England.
The research hospital will bring together the clinical expertise of Cambridge University Hospitals with the scientific expertise of the University of Cambridge and the Cancer Research UK Cambridge Major Centre.
Professor Richard Gilbertson, Director of the CRUK Cambridge Centre and Group Leader at the Institute said: âI would like to take the opportunity to thank all those involved in the incredible partnership between the CRUK Cambridge Centre, Cambridge University Hospitals NHS Trust and the University that has made this possible.â
Todayâs announcement gives a true âgreen lightâ to the building of this much needed facility for our patients.â
Roland Sinker, CEO Cambridge University Hospitals, said: âWe welcome the Prime Ministerâs funding announcement for the Cambridge Cancer Research Hospital. Cambridge Cancer will rewrite the story of cancer; it will bring together world-class clinicians from Addenbrookeâs Hospital with cutting-edge Cambridge research and industry, enabling early detection of cancer and delivering bespoke, precision treatments that will radically improve patient outcomes.
âThis national facility will bring hope for cancer patients regionally, nationally and internationally, and we look forward to progressing this project at a rapid pace.â
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more